These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6953727)

  • 1. Clinical evaluation of combined treatment with methadone and psychotropic drugs in cancer patients.
    Breivik H; Rennemo F
    Acta Anaesthesiol Scand Suppl; 1982; 74():135-40. PubMed ID: 6953727
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of psychotropic drugs in the treatment of chronic, severe pains.
    Kocher R
    Eur Neurol; 1976; 14(6):458-64. PubMed ID: 991883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pain clinic: the use of systemic analgesics.
    Warfield CA; Stein JM
    Hosp Pract (Off Ed); 1982 Jul; 17(7):88A-88B, 88D, 88H passim. PubMed ID: 6179845
    [No Abstract]   [Full Text] [Related]  

  • 4. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral methadone for relief of chronic pain from cancer.
    Portnow JM; Corbett RJ
    N Engl J Med; 1982 Apr; 306(16):989-90. PubMed ID: 7062980
    [No Abstract]   [Full Text] [Related]  

  • 7. Does intravenous methadone provide longer lasting analgesia than intravenous morphine? A randomized, double-blind study.
    Grochow L; Sheidler V; Grossman S; Green L; Enterline J
    Pain; 1989 Aug; 38(2):151-7. PubMed ID: 2488674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-controlled analgesia with intravenous L-methadone in a child with cancer pain refractory to high-dose morphine.
    Sabatowski R; Kasper SM; Radbruch L
    J Pain Symptom Manage; 2002 Jan; 23(1):3-5. PubMed ID: 11779660
    [No Abstract]   [Full Text] [Related]  

  • 9. Methadone and intravenous morphine requirements. Treatment of pain due to advanced cancer.
    Kepes ER; Raj S; Thomas P; Vemulapalli K
    N Y State J Med; 1983 Jun; 83(7):925-7. PubMed ID: 6193466
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful use of methadone in nociceptive cancer pain unresponsive to morphine.
    Leng G; Finnegan MJ
    Palliat Med; 1994; 8(2):153-5. PubMed ID: 7521715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with ibuprofen and methadone for chronic cancer pain.
    Ferrer-Brechner T; Ganz P
    Am J Med; 1984 Jul; 77(1A):78-83. PubMed ID: 6380281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study on oral administration of morphine and methadone in the treatment of cancer pain.
    Ventafridda V; Ripamonti C; Bianchi M; Sbanotto A; De Conno F
    J Pain Symptom Manage; 1986; 1(4):203-7. PubMed ID: 3537160
    [No Abstract]   [Full Text] [Related]  

  • 13. The rediscovery of methadone for cancer pain management.
    Clark KJ; Turner K
    Med J Aust; 2001 May; 174(10):547-8. PubMed ID: 11419789
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home.
    Mercadante S; Casuccio A; Agnello A; Serretta R; Calderone L; Barresi L
    J Clin Oncol; 1998 Nov; 16(11):3656-61. PubMed ID: 9817288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic agents in the management of chronic pain.
    Adler RH
    J Human Stress; 1978 Jun; 4(2):13-7. PubMed ID: 659851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comments on Ripamonti et al., Pain, 70 (1997) 109-115.
    Morley JS; Makin MK
    Pain; 1997 Oct; 73(1):114-5. PubMed ID: 9414068
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidural and intrathecal opiates: cerebrospinal fluid and plasma profiles in patients with chronic cancer pain.
    Max MB; Inturrisi CE; Kaiko RF; Grabinski PY; Li CH; Foley KM
    Clin Pharmacol Ther; 1985 Dec; 38(6):631-41. PubMed ID: 2415286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone for pain relief in disseminated malignant disease.
    Pierce J; Ya Deau RE
    Oncol Nurs Forum; 1980; 7(2):14-7. PubMed ID: 6899326
    [No Abstract]   [Full Text] [Related]  

  • 20. Diclofenac does not modify methadone bioavailability in cancer patients.
    Bianchi M; Clavenna A; Groff L; Zecca E; Ripamonti C
    J Pain Symptom Manage; 1999 Apr; 17(4):227-9. PubMed ID: 10203873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.